3-Bromo-6-fluoro-2-methylpyridine | CAS:375368-83-5

We serve 3-Bromo-6-fluoro-2-methylpyridine CAS:375368-83-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-6-fluoro-2-methylpyridine

Chemical Name: 3-Bromo-6-fluoro-2-methylpyridine
CAS.NO: 375368-83-5
Synonyms:3-bromo-6-fluoro-2-methylpyridine;
5-Bromo-2-Fluoro-6-Picoline;
Molecular Formula: C6H5BrFN
Molecular Weight: 190.01300
 
Physical and Chemical Properties:
Density: 1.6±0.1 g/cm3
Melting point: /
Boiling point: 189.5±35.0 °C at 760 mmHg
Flash point: 68.4±25.9 °C
Index of Refraction: 1.530
 
Specification:
Appearance: Light yellow powder
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate



Contact us for information like 3-Bromo-6-Fluoro-2-Methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-2-Fluoro-6-Picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-2-Fluoro-6-Picoline Use and application,5-Bromo-2-Fluoro-6-Picoline technical grade,usp/ep/jp grade.


Related News: Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.”2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid manufacturer From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.1-Bromo-2-nitrobenzene supplier The first case of the 2019 novel coronavirus in Massachusetts has been confirmed in a man returning from Wuhan, China who is in his 20s and lives in Boston. The Massachusetts Department of Public Health (DPH) and the Boston Public Health Commission (BPHC) were notified by the US Centers for Disease Control and Prevention (CDC) of the positive test results late Friday evening. This is the eighth case of infection with 2019 novel coronavirus reported in the United States. The risk to the public from the 2019 novel coronavirus remains low in Massachusetts.4-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine-1-carboxylic acid tert-butyl ester vendor The first case of the 2019 novel coronavirus in Massachusetts has been confirmed in a man returning from Wuhan, China who is in his 20s and lives in Boston. The Massachusetts Department of Public Health (DPH) and the Boston Public Health Commission (BPHC) were notified by the US Centers for Disease Control and Prevention (CDC) of the positive test results late Friday evening. This is the eighth case of infection with 2019 novel coronavirus reported in the United States. The risk to the public from the 2019 novel coronavirus remains low in Massachusetts.Active pharmaceutical ingredients directly impact disease.